UACC893（人乳腺癌細胞）
CBP60398
詢(xún) 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數據庫
| I. General information | |
| Synonyms: | UACC893 |
| Background: | This cell line was established by A. Liebovitz and associates in 1987 from breast tissue removed at lumpectomy to remove a ductal carcinoma (stage II). |
| Species: | Homo sapiens, human |
| Tissue: | mammary gland; breast |
| Disease: | primary ductal carcinoma |
| Gender: | Caucasian, 57 years, female |
| Morphology: | epithelial |
| Growth Mode: | adherent |
| Doubling Time: | 100 hrs |
| DNA Profile: | Amelogenin: X CSF1PO: 11,12 D13S317: 13 D16S539: 9,13 D5S818: 12 D7S820: 11 THO1: 6,9.3 TPOX: 8 vWA: 16,17 Cobioer’s Cell Line Authentication Service |
| Culture Medium: |
DMEM+10%FBS UACC893完全培養基，# CBP60398M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | N/A |
| Receptor Expression: | N/A |
| Oncogene: | N/A |
| Genes Expressed: | N/A |
| Cellular Products: | N/A |
| Tumor Formation: | N/A |
| Comments: | The cells exhibit a 20 fold amplification of the HER-2/neu oncogene sequence. The cells grow very slowly, and growth can be enhanced by using 20% fetal bovine serum and adding epidermal growth factor (10 ng/mL) to the medium. They are negative for estrogen receptors, progesterone receptors and P glycoprotein. For more information, please contact Cobioer (4008-750-250). |
